Literature DB >> 18843781

Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis.

Yolanda Braun-Moscovici1, Daniel E Furst, Doron Markovits, Alexander Rozin, Philip J Clements, Abraham Menahem Nahir, Alexandra Balbir-Gurman.   

Abstract

OBJECTIVE: .Sclerodactyly with acroosteolysis (AO) and calcinosis are prominent features of systemic sclerosis (SSc), but the pathogenesis of these findings is poorly understood. Vitamin D and parathyroid hormone (PTH) have a crucial role in bone metabolism and resorption and may affect AO and calcinosis. We assessed vitamin D and PTH in patients with SSc.
METHODS: Medical records of 134 consecutive patients with SSc (American College of Rheumatology criteria) followed at the rheumatology department during the years 2003-2006 were reviewed for clinical assessment, laboratory evaluation [including 25(OH) vitamin D, calcium, phosphorus, alkaline phosphatase, PTH, creatinine, and albumin]; imaging data confirming AO and/or calcinosis. Patients followed routinely at least once a year were included (81 patients). Of these, 60 patients' medical records were found to have complete, relevant clinical, laboratory, and radiographic imaging.
RESULTS: Thirteen patients had diffuse disease and 47 limited disease - 51 women and 9 men, 44 Jews and 16 Arabs; mean age 55 +/- 14 years; disease duration 8 +/- 6 years. AO with or without calcinosis was observed in 42 patients (70%). Vitamin D deficiency was found in 46% of patients (16 out of 44 Jewish patients, 10 out of 16 Arab patients). PTH was elevated in 21.7% of patients. Significant correlations were observed between acroosteolysis and PTH (p = 0.015), calcinosis (p = 0.009), and disease duration (p = 0.008), and between PTH and vitamin D levels (p = 0.01). All patients had normal serum concentrations of calcium, phosphorus, magnesium, and albumin, and liver and kidney functions.
CONCLUSION: In this group of Mediterranean patients with SSc, the incidence of vitamin D deficiency and secondary hyperparathyroidism was surprisingly high. This finding correlated with the occurrence of AO and calcinosis. Low levels of vitamin D may reflect silent malabsorption and might be a risk factor for secondary hyperparathyroidism and bone resorption. Traditional dress habits and low exposure to sun may contribute to vitamin D deficiency in an Arab population but do not explain all the findings. The pathogenesis of these findings needs to be corroborated in other SSc populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18843781     DOI: 10.3899/jrheum.071171

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  22 in total

1.  Very low levels of vitamin D in systemic sclerosis patients.

Authors:  Paola Caramaschi; Alessandra Dalla Gassa; Orazio Ruzzenente; Alessandro Volpe; Viviana Ravagnani; Ilaria Tinazzi; Giovanni Barausse; Lisa M Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2010-05-09       Impact factor: 2.980

Review 2.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

3.  Vitamin D in systemic sclerosis.

Authors:  Laura Belloli; Nicola Ughi; Bianca Marasini
Journal:  Clin Rheumatol       Date:  2010-09-28       Impact factor: 2.980

4.  Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency.

Authors:  Samuel Katsuyuki Shinjo; Eloisa Bonfá; Valéria de Falco Caparbo; Rosa Maria Rodrigues Pereira
Journal:  Rheumatol Int       Date:  2010-03-25       Impact factor: 2.631

5.  Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature.

Authors:  Dilia Giuggioli; M Colaci; G Cassone; P Fallahi; F Lumetti; A Spinella; F Campomori; A Manfredi; C U Manzini; A Antonelli; C Ferri
Journal:  Clin Rheumatol       Date:  2017-01-09       Impact factor: 2.980

6.  Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Fahd Wafki; Fatima Znat; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-09-27       Impact factor: 2.631

Review 7.  Acro-osteolysis.

Authors:  Anna Botou; Athanasios Bangeas; Ioannis Alexiou; Lazaros I Sakkas
Journal:  Clin Rheumatol       Date:  2016-10-29       Impact factor: 2.980

8.  Low vitamin D status in systemic sclerosis and the impact on disease phenotype.

Authors:  Laura Groseanu; Violeta Bojinca; Tania Gudu; Ioana Saulescu; Denisa Predeteanu; Andra Balanescu; Florian Berghea; Daniela Opris; Andreea Borangiu; Cosmin Constantinescu; Magda Negru; Ruxandra Ionescu
Journal:  Eur J Rheumatol       Date:  2016-02-01

9.  Acroosteolysis in systemic sclerosis: An insight into hypoxia-related pathogenesis.

Authors:  Simon Siao-Pin; Laura-Otilia Damian; Laura Mirela Muntean; Simona Rednic
Journal:  Exp Ther Med       Date:  2016-10-05       Impact factor: 2.447

10.  Endothelin-1, α-Klotho, 25(OH) Vit D levels and severity of disease in scleroderma patients.

Authors:  Mehrzad Hajialilo; Parisa Noorabadi; Sepideh Tahsini Tekantapeh; Aida Malek Mahdavi
Journal:  Rheumatol Int       Date:  2017-08-22       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.